US Stock MarketDetailed Quotes

RLAY Relay Therapeutics

Watchlist
  • 4.750
  • +0.110+2.37%
Close Nov 22 16:00 ET
  • 4.900
  • +0.150+3.16%
Post 20:01 ET
795.07MMarket Cap-1819P/E (TTM)

Relay Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Relay Therapeutics Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
80.00K
0
-80.00K
Miss Est.
-99.68%
-100.00%
-100.00%
EPS
-0.77
-0.63
+0.14
Beat Est.
-42.42%
-16.67%
+18.06%
Analyst Rating
Strong Buy

Nov 8, 2024

Relay Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 50.000K--
--2024/Q4-- / 80.000K--
Nov 6, 20242024/Q30.000 / 80.000K--
Aug 6, 20242024/Q20.000 / 88.890K--
May 2, 20242024/Q110.007M / 109.090K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 50.000K--
--2024/Q4-- / 80.000K--
Nov 6, 20242024/Q30.000 / 80.000K--
Aug 6, 20242024/Q20.000 / 88.890K--
May 2, 20242024/Q110.007M / 109.090K--

Unlock Free Earnings Estimates

Relay Therapeutics Earnings Reports

  • Relay Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 05:20

  • Relay Therapeutics | 8-K: Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights

    Nov 7 05:13

  • Relay Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 04:20

  • Relay Therapeutics | 8-K: Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights

    Aug 7 04:18

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 8, 2024

    Strong Buy

    • Buy

      90.91%

    • Hold

      9.09%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data